<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="8058" whole_study_id="6180" phs="000291" v="2" p="1" createDate="2012-04-30T11:51:24-05:00" completedByGPADate="2016-02-26T17:09:08-05:00" modDate="2022-01-25T16:16:07-05:00" maxParentChildStudyModDate="2022-01-25T16:16:07-05:00" handle="ESP_LungGO_LHS_COPD" num_participants="96"><StudyInfo accession="phs000291.v2.p1" parentAccession="phs000291.v2.p1"><BioProject id="PRJNA74819" entrez_id="74819" type="bp_admin_access"/><BioProject id="PRJNA74821" entrez_id="74821" type="bp_data_submission"/><StudyNameEntrez>NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Lung Health Study of Chronic Obstructive Pulmonary Disease)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>sra</StudyType><StudyType>resequencing</StudyType></StudyTypes><SraStorages/><Funding>HL 102923</Funding></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="KCBARNES" aid="2" auth="eRA" login="KCBARNES" fname="Kathleen" mname="C" lname="Barnes" email="kathleen.barnes@cuanschutz.edu"><Role>PI</Role><Organization>UNIVERSITY OF COLORADO DENVERJOHNS HOPKINS UNIVERSITY</Organization></Person><Person nedid="0013114408" aid="1" auth="cit" login="ganw2" fname="Weiniu" mname="" lname="Gan" email="ganw2@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="3 months"><acknowledgement_statement>This study is part of the NHLBI Grand Opportunity Exome Sequencing Project (GO-ESP).  Funding for GO-ESP was provided by NHLBI grants RC2 HL103010 (HeartGO), RC2 HL102923 (LungGO) and RC2 HL102924 (WHISP).  The exome sequencing was performed through NHLBI grants RC2 HL102925 (BroadGO) and RC2 HL102926 (SeattleGO).
The authors wish to thank the supported effort of the faculty and staff members of the Johns Hopkins University Bayview Genetics Research Facility, NHLBI grant HL066583 (Garcia/Barnes, PI) and NHGRI grant HG004738 (Barnes/Hansel, PI).  The Lung Health Study was supported by U.S. Government contract No. N01-HR-46002 from the Division of Lung Diseases of the National Heart, Lung and Blood Institute.  The principal investigators and senior staff of the clinical and coordinating centers, the NHLBI, and members of the Safety and Data Monitoring Board of the Lung Health Study can be found at http://www.biostat.umn.edu/lhs/ and as follows: 
Case Western Reserve University, Cleveland, OH: M.D. Altose, M.D. (Principal Investigator), C.D. Deitz, Ph.D. (Project Coordinator); Henry Ford Hospital, Detroit, MI: M.S. Eichenhorn, M.D. (Principal Investigator), K.J. Braden, A.A.S. (Project Coordinator), R.L. Jentons, M.A.L.L.P. (Project Coordinator); Johns Hopkins University School of Medicine, Baltimore, MD: R.A. Wise, M.D. (Principal Investigator), C.S. Rand, Ph.D. (Co-Principal Investigator), K.A. Schiller (Project Coordinator); Mayo Clinic, Rochester, MN: P.D. Scanlon, M.D. (Principal Investigator), G.M. Caron (Project Coordinator), K.S. Mieras, L.C. Walters; Oregon Health Sciences University, Portland: A.S. Buist, M.D. (Principal Investigator), L.R. Johnson, Ph.D. (LHS Pulmonary Function Coordinator), V.J. Bortz (Project Coordinator); University of Alabama at Birmingham: W.C. Bailey, M.D. (Principal Investigator), L.B. Gerald, Ph.D., M.S.P.H. (Project Coordinator); University of California, Los Angeles: D.P. Tashkin, M.D. (Principal Investigator), I.P. Zuniga (Project Coordinator); University of Manitoba, Winnipeg: N.R. Anthonisen, M.D. (Principal Investigator, Steering Committee Chair), J. Manfreda, M.D. (Co-Principal Investigator), R.P. Murray, Ph.D. (Co-Principal Investigator), S.C. Rempel-Rossum (Project Coordinator); University of Minnesota Coordinating Center, Minneapolis: J.E. Connett, Ph.D. (Principal Investigator), P.L. Enright, M.D., P.G. Lindgren, M.S., P. O'Hara, Ph.D., (LHS Intervention Coordinator), M.A. Skeans, M.S., H.T. Voelker; University of Pittsburgh, Pittsburgh, PA: R.M. Rogers, M.D. (Principal Investigator), M.E. Pusateri (Project Coordinator); University of Utah, Salt Lake City: R.E. Kanner, M.D. (Principal Investigator), G.M. Villegas (Project Coordinator); Safety and Data Monitoring Board: M. Becklake, M.D., B. Burrows, M.D. (deceased), P. Cleary, Ph.D., P. Kimbel, M.D. (Chairperson; deceased), L. Nett, R.N., R.R.T. (former member), J.K. Ockene, Ph.D., R.M. Senior, M.D. (Chairperson), G.L. Snider, M.D., W. Spitzer, M.D. (former member), O.D. Williams, Ph.D.; Morbidity and Mortality Review Board: T.E. Cuddy, M.D., R.S. Fontana, M.D., R.E. Hyatt, M.D., C.T. Lambrew, M.D., B.A. Mason, M.D., D.M. Mintzer, M.D., R.B. Wray, M.D.; National Heart, Lung, and Blood Institute staff, Bethesda, MD: S.S. Hurd, Ph.D. (Former Director, Division of Lung Diseases), J.P. Kiley, Ph.D. (Former Project Officer and Director, Division of Lung Diseases), G. Weinmann, M.D. (Former Project Officer and Director, Airway Biology and Disease Program, DLD), M.C. Wu, Ph.D. (Division of Cardiovascular Sciences).
</acknowledgement_statement><ic_specific_access_term>Use of the data is limited only by the terms of the model Data Use Certification. These data are approved for general research use.
</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_old_cert" gsr_mode_label="Unrestricted access (institution responded that the study is not sensitive without submitting a new Institutional Certification)"/><ConsentGroup uid="502" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>These data are approved for general research use.</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="502"><StudyTo study_uid="10253" name="dbGaP Collection: Compilation of Individual-Level Genomic Data for General Research Use" accession="phs000688.v1"><ConsentGroupTo uid="1115" name="GRU"/></StudyTo></ConsentGroupLink><ConsentGroupLink cg_uid_from="502"><StudyTo study_uid="37911" name="NHLBI Big Data Analysis Heart Failure Challenge Data Collection" accession="phs001991.v1"><ConsentGroupTo uid="3884" name="GRU"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="6180" whole_study_id="6180" phs="000291" v="1" p="1" createDate="2010-05-12T10:42:53-05:00" modDate="2020-09-01T10:30:42-05:00" maxParentChildStudyModDate="2020-09-01T10:30:42-05:00" handle="ESP_LungGO_LHS_COPD" num_participants="96"><StudyInfo accession="phs000291.v1.p1" parentAccession="phs000291.v1.p1"><BioProject id="PRJNA74819" entrez_id="74819" type="bp_admin_access"/><BioProject id="PRJNA74821" entrez_id="74821" type="bp_data_submission"/><StudyNameEntrez>NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Lung Health Study of Chronic Obstructive Pulmonary Disease)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>sra</StudyType><StudyType>resequencing</StudyType></StudyTypes><SraStorages/><Description>
&lt;p&gt;The NHLBI "Grand Opportunity" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery  Act investment,    was designed to identify genetic variants in coding regions (exons) of the human genome (the "exome") that are associated with    heart, lung and blood diseases.  These and related diseases that are of high impact to public health and individuals from    diverse racial and ethnic groups will be studied.  These data may help researchers understand the causes of disease,    contributing to better ways to prevent, diagnose, and treat diseases, as well as determine whether to tailor prevention    and treatments to specific populations.  This could lead to more effective treatments and reduce the likelihood of side effects.     GO-ESP is comprised of five collaborative components: 3 cohort consortia - HeartGO, LungGO, and WHISP - and 2 sequencing centers -    BroadGO and SeattleGO.&lt;/p&gt;   &lt;p&gt;The Lung Health Study I was a randomized multicenter clinical trial with 5887 participants carried out from October 1986  to April 1994, designed to test the effectiveness of smoking cessation and bronchodilator administration in smokers aged 35  to 60 with mild lung function impairment. Participants were randomly assigned to one of three groups:   &lt;ul&gt;    &lt;li&gt;usual care, who received no intervention&lt;/li&gt;    &lt;li&gt;smoking intervention with the inhaled bronchodilator ipratroprium bromide&lt;/li&gt;    &lt;li&gt;smoking intervention with an inhaled placebo&lt;/li&gt;   &lt;/ul&gt;  &lt;/p&gt;  &lt;p&gt;The effect of intervention was evaluated by the rate of decline of forced expiratory volume in one second (FEV1).&lt;/p&gt;
 </Description><Attributions><Header title="Principal Investigator"><AttrName>Kathleen Barnes, PhD</AttrName><Institution>Johns Hopkins University, Baltimore, MD, USA</Institution></Header><Header title="Co-Investigator"><AttrName>Nadia Hansel, MD, PhD</AttrName><Institution>Johns Hopkins University, Baltimore, MD, USA</Institution></Header></Attributions><StudyURLs><Url name="Lung Health Study" url="http://www.biostat.umn.edu/lhs/"/><Url name="NHLBI GO ESP Project" url="http://esp.gs.washington.edu/drupal/"/></StudyURLs><Publications><Publication><Pubmed pmid="19196818"/></Publication><Publication><Pubmed pmid="19131638"/></Publication><Publication><Pubmed pmid="19359268"/></Publication><Publication><Pubmed pmid="8500311"/></Publication><Publication><Pubmed pmid="2048803"/></Publication><Publication><Pubmed pmid="16700921"/></Publication><Publication><Pubmed pmid="17071067"/></Publication></Publications><Funding>HL 102923</Funding></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="KCBARNES" aid="2" auth="eRA" login="KCBARNES" fname="Kathleen" mname="C" lname="Barnes" email="kathleen.barnes@cuanschutz.edu"><Role>PI</Role><Organization>UNIVERSITY OF COLORADO DENVERJOHNS HOPKINS UNIVERSITY</Organization></Person><Person nedid="0013114408" aid="1" auth="cit" login="ganw2" fname="Weiniu" mname="" lname="Gan" email="ganw2@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011073112" aid="1" auth="cit" login="paltood" fname="Dina" mname="N" lname="Paltoo" email="dp249p@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="3 months"><DUC><File uri="dbgapssws.cgi?blob_id=7114&amp;file=get&amp;page=file" filename="Sequencing DUC LHS Final revised 6 10 11.doc" md5="24b4cbfdc02d7bdb676dd6fd0e63734b" size="74752" modDate="2011-06-29T11:45:21-05:00" content-type="application/octet-stream"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=17182&amp;file=get&amp;page=file" filename="Sequencing DUC LHS Final revised 6 10 11.doc.pdf" md5="f5affff47cb57f53caf55c71b64f8527" size="154620" modDate="2015-10-05T16:09:10-05:00" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="183" CGType="cg_class_other" title="Exchange Area" name="EA" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>These restrictions are to ensure that the data will be properly utilized by all IRB approved submitting investigators.</Use-Restriction></ConsentGroup><ConsentGroup uid="502" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>These data are approved for general research use.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>